PlainRecalls
FDA Drug Critical Class I Ongoing

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Reported: September 11, 2024 Initiated: August 1, 2024 #D-0649-2024

Product Description

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Details

Units Affected
44,208 containers
Distribution
Nationwide in the USA
Location
Round Lake, IL

Frequently Asked Questions

What product was recalled?
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04. Recalled by Baxter Healthcare Corporation. Units affected: 44,208 containers.
Why was this product recalled?
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 11, 2024. Severity: Critical. Recall number: D-0649-2024.